Tumor-specific Wnt/β-catenin signaling promotes immune evasion of tumor cells, enhances Treg production, inhibits CD8 + T-cell activation and invasion, converts DCs to an immunoregulatory phenotype, and differentiates CD8 + T cells into effector cells82. This evidence concerns the gene CD8A and neoplasm.